Coronary artery disease

There are 3,376 papers on coronary artery disease in aging research: 202 trials and 2,390 observational studies in people, 21 in animals, 5 in cells, 640 reviews. The newest story, Nov 19, 2026: “Genetic study finds no lower artery disease risk for immune target”.

Disease

3,376 papers study it623 more mention it1,211 findings

MeSH

505 new papers in 30 daysSee all 3,999 papers on coronary artery disease

At a glance

Human studies link coronary artery disease with biological-age acceleration, lipid and inflammatory markers, and polygenic risk. Human trial reports describe lower coronary disease risk with omega-3 fatty acids, while a screening trial shows no clear effect. In a study of adults with congenital heart disease, coronary disease is associated with higher mortality.

1,211 findings in 876 papers from 1990 to 2026, 231 of them since April 2026

“there was 1.21% absolute CHD risk reduction in the top tertile of the expected benefit, compared with the average effect of 0.47% risk reduction.”
Identification of individuals who benefit from omega-3 fatty acid supplementation to prevent coronary heart disease: a machine-learning analysis of the VITALEuropean journal of epidemiology2025doi:10.1007/s10654-025-01259-0
  • Human trial202
  • Humans2,390
  • Animals21
  • Cells5
  • In silico83

Interventions

16

Hormone replacement therapy

downin humans2no changein humans1

3 studies
  1. Hormone replacement therapy showed no clear effect on coronary artery disease in humans (history of treated hyperlipidemia or untreated with favorable lipid profiles).

    “Randomization to oral MHT did not increase CHD risk in participants with a history of treated hyperlipidemia or in untreated participants with favorable lipid profiles”

    Human trialhistory of treated hyperlipidemia or untreated with favorable lipid profilesoralfemales

    Influence of Cardiometabolic Status on Cardiovascular Effects of Oral Menopausal Hormone Therapy

    Obstetrics and gynecology

  2. Hormone replacement therapy protects against coronary artery disease in humans (timing of hormone replacement therapy initiation).

    “estrogen may have an important protective role in CHD, particularly in women initiating treatment below age 60 years”

    Reviewtiming of hormone replacement therapy initiationfemales

    Primary prevention of coronary heart disease in women

    Post reproductive health

  3. Hormone replacement therapy protects against coronary artery disease in humans (started early after menopause (timing hypothesis)).

    “Recent evidence supports the cardioprotective effects of HRT when started early after menopause, ideally within ten years or before the age of sixty, in line with the "timing hypothesis".”

    Reviewstarted early after menopause (timing hypothesis)

    Terapia ormonale sostitutiva e terapie ormonali

    Cardiologia Ambulatoriale

More on Hormone replacement therapy

Systematic screening

no changein humans1RR 0.76

1 study
  1. Systematic screening showed no clear effect on coronary artery disease in humans (pooled HR/RR 0.76; 95% CI 0.48–1.19).

    “Screening did not significantly reduce major cardiovascular outcomes in the four trials included in the quantitative synthesis (pooled HR/RR 0.76; 95% CI 0.48–1.19).”

    Human trial

    Screening Strategies for Silent Myocardial Ischemia in Individuals With Diabetes Without Known Coronary Artery Disease: Systematic Review and Meta-Analysis

    Clinical cardiology

  2. Systematic screening showed no clear effect on coronary artery disease in asymptomatic adults with diabetes and no known CAD (pooled HR/RR 0.76; 95% CI 0.48-1.19).

    “Screening did not significantly reduce major cardiovascular outcomes in the four trials included in the quantitative synthesis (pooled HR/RR 0.76; 95% CI 0.48-1.19).”

    Human trialin asymptomatic adults with diabetes and no known CADn = 3,315

    Screening Strategies for Silent Myocardial Ischemia in Individuals With Diabetes Without Known Coronary Artery Disease: Systematic Review and Meta-Analysis

    Clinical cardiology

More on Systematic screening

Beta-carotene

no changein humans1RR 0.99

1 study
  1. Beta-carotene showed no clear effect on coronary artery disease in humans (RR = 0.99, 95% CI = 0.82 to 1.21).

    “there is no strong evidence against the null hypothesis that beta-carotene intake does not affect risk of CHD”

    ReviewQuantitative triangulation of randomized controlled trials, Mendelian randomization, and conventional multivariable regression

    A quantitative approach to evidence triangulation: development of a framework to address rigour and relevance

    European journal of epidemiology

More on Beta-carotene

Sleep duration

no changein humans1

1 study
  1. Sleep duration was not clearly linked with coronary artery disease in humans (Short sleep duration with excellent sleep quality) (PR 0.94, 95% CI 0.79-1.11; p=0.47).

    “short sleep duration with excellent quality was not associated with higher CHD prevalence (PR 0.94, 95% CI 0.79-1.11; p=0.47)”

    HumansShort sleep duration with excellent sleep quality

    Poor sleep quality linked to more heart disease and stroke

    AHA Scientific Sessions 2026 abstract

More on Sleep duration

Brisk walking

downin humans1

1 study
  1. Brisk walking protects against coronary artery disease in humans (halved).

    “brisk walking halved the risk of coronary events and stroke.”

    Review

    Epidemiological factors associated with cardiovascular diseases in older adults: narrative review

    Cuaderno de enfermería. Revista científica.

More on Brisk walking

Conjugated equine estrogens + medroxyprogesterone acetate

no changein humans1HR 0.59

1 study
  1. Conjugated equine estrogens + medroxyprogesterone acetate showed no clear effect on coronary artery disease in humans (normal low-density lipoprotein (LDL) cholesterol levels (less than 130 mg/dL)) (HR 0.59; 95% CI, 0.31-1.10).

    “the CHD risk in untreated participants with normal low-density lipoprotein (LDL) cholesterol levels (less than 130 mg/dL) was similar to that of placebo-treated participants (hazard ratio [HR] 0.59; 95% CI, 0.31-1.10)”

    Human trialnormal low-density lipoprotein (LDL) cholesterol levels (less than 130 mg/dL)oral0.625 mg/d CEE + 2.5 mg/d MPAfemales

    Influence of Cardiometabolic Status on Cardiovascular Effects of Oral Menopausal Hormone Therapy

    Obstetrics and gynecology

More on Conjugated equine estrogens + medroxyprogesterone acetate

Age at menopause

no changein humans1HR 0.95

1 study
  1. Age at menopause was not clearly linked with coronary artery disease in humans (women with type 1 diabetes) (HR 0.95, 95% CI 0.89–1.01).

    “Although age at FMP was not associated with CAD (HR=0.95, 95% CI 0.89, 1.01)”

    Humanswomen with type 1 diabetes32 yearsfemalesn = 121

    Age at Menopause Modifies the Effect of Clinical Risk Factors on Coronary Artery Disease (CAD) Incidence in Women with Type 1 Diabetes (T1D)

    ADA Scientific Sessions 2026 abstract

More on Age at menopause

Breakfast frequency

no changein humans1

1 study
  1. Breakfast frequency was not clearly linked with coronary artery disease in humans (overall cohort).

    “neither breakfast frequency nor breakfast timing was associated with risk of CAD or MI in males, females, or altogether.”

    Humansoverall cohortup to 26 yearsn = 4,070

    Prospective study of breakfast frequency and timing and risk of myocardial infarction and coronary artery disease in community-dwelling older adults: The Cardiovascular Health Study

    The journal of nutrition, health & aging

More on Breakfast frequency

Lipoprotein

upin humans1OR 1.36

1 study
  1. Lipoprotein is linked with higher coronary artery disease in humans (direct causal effect independent of LDL-C, network deconvolution Mendelian randomization) (OR 1.36 (95% CI 1.21-1.54)).

    “independent of low-density lipoprotein cholesterol, on coronary artery disease (OR: 1.36; 95% CI: 1.21-1.54)”

    Humansdirect causal effect independent of LDL-C, network deconvolution Mendelian randomizationn = 425,677

    Lp(a) Has Specific Effects on Coronary Artery Disease Independent of LDL-C: A Mendelian Randomization Study

    JACC. Advances

More on Lipoprotein

Behavioral interventions

downin silico1

1 study
  1. Behavioral interventions prevent coronary artery disease in silico (top 20% of the PRS distribution) (72 CAD events prevented (3.6% absolute event reduction)).

    “PRS-guided prevention was projected to prevent 72 CAD events among 2000 high-risk children (3.6% absolute event reduction)”

    In silicotop 20% of the PRS distributionn = 2,000

    Economic modeling of polygenic risk prediction of coronary artery disease in childhood

    NPJ cardiovascular health

More on Behavioral interventions

All 16

Effects

35

IL-6

upin humans1

1 study
  1. Coronary artery disease is linked with higher IL-6 in humans.

    “Across the CAD spectrum, a stepwise increase in systemic IL-6, TNF-α, MCP-1, ICAM-1, and VCAM-1 were observed, reaching peak levels during acute STEMI.”

    Humansstepwise rise from healthy subjects through stable CAD to acute STEMI; MCP-1, ICAM-1 and VCAM-1 rose similarly

    Gliflozin therapy attenuates persistent systemic inflammation and monocyte metabolic dysfunction post-ACS: a comparative study across the CAD spectrum

    ESC Congress 2026 abstract

More on IL-6

Digits Forward performance

downin humans1

1 study
  1. Coronary artery disease is linked with worse digits Forward performance in humans (multivariable linear regression adjusted for age, sex, and HIV status) (b = 0.386; 95% CI, 0.028 to 0.744; P = 0.035; q = 0.210).

    “nominally associated with poorer performance on Digits Forward (a measure of attention and immediate verbal span) (b = 0.386; 95% CI, 0.028 to 0.744; P = 0.035; q = 0.210).”

    Humansmultivariable linear regression adjusted for age, sex, and HIV statusn = 512

    Coronary artery disease and neurocognitive performance among older adults in Uganda

    Research squarePreprint

Color Trails 2 performance

downin humans1

1 study
  1. Coronary artery disease is linked with worse color Trails 2 performance in humans (multivariable linear regression adjusted for age, sex, and HIV status) (b = 0.502; 95% CI, 0.184 to 0.821; P = 0.002; q = 0.026).

    “CAD was associated with poorer performance on Color Trails 2 (a measure of executive function) (b = 0.502; 95% CI, 0.184 to 0.821; P = 0.002; q = 0.026)”

    Humansmultivariable linear regression adjusted for age, sex, and HIV statusn = 512

    Coronary artery disease and neurocognitive performance among older adults in Uganda

    Research squarePreprint

Global cognition

no changein humans1

1 study
  1. Coronary artery disease was not clearly linked with global cognition in humans (multivariable linear regression adjusted for age, sex, and HIV status) (b = 0.093 SD units; 95% CI, - 0.122 to 0.308; P = 0.397).

    “CAD was not associated with global cognition (b = 0.093 SD units; 95% CI, - 0.122 to 0.308; P = 0.397).”

    Humansmultivariable linear regression adjusted for age, sex, and HIV statusn = 512

    Coronary artery disease and neurocognitive performance among older adults in Uganda

    Research squarePreprint

Cellular senescence

upin reviews1

1 study
  1. Coronary artery disease induces cellular senescence.

    “Conversely, CAD-related stressors, including atherosclerotic injury, disturbed flow, myocardial ischaemia and ischaemia-reperfusion injury, can induce local senescence programmes”

    Review

    Cellular senescence at the bidirectional interface between ageing and coronary artery disease

    Ageing research reviews

More on Cellular senescence

Exercise tolerance

downin humans1

1 study
  1. Coronary artery disease is linked with worse exercise tolerance in residential care home residents (168.4 ± 84.4 m vs 312.7 ± 89.4 m, p < 0.001).

    “participants in Group I covered a mean distance of 312.7 ± 89.4 m, whereas those in Group II covered 168.4 ± 84.4 m (p < 0.001).”

    Humansin residential care home residentsmalesn = 74

    Functional Capacity and Exercise Tolerance in Residential Care Home Residents with Treated Arterial Hypertension and Coronary Heart Disease

    Journal of clinical medicine

Functional capacity

downin humans1

1 study
  1. Coronary artery disease is linked with worse functional capacity in residential care home residents (5.2 ± 2.5 vs 8.7 ± 2.1 points, p < 0.001).

    “The mean SPPB score was 8.7 ± 2.1 points in Group I and 5.2 ± 2.5 points in Group II (p < 0.001).”

    Humansin residential care home residentsmalesn = 74

    Functional Capacity and Exercise Tolerance in Residential Care Home Residents with Treated Arterial Hypertension and Coronary Heart Disease

    Journal of clinical medicine

Frailty

mediatesin silico1

1 study
  1. Coronary artery disease mediates frailty in silico (two-step MR analysis of leisure screen time and frailty) (accounting for 7.2% of the total effect).

    “BMI, HTN, CAD, and T2D showed separate, modest mediation signals, accounting for 11.4%, 12.7%, 7.2%, and 7.8% of the total effect, respectively.”

    In silicotwo-step MR analysis of leisure screen time and frailty

    Leisure screen time, cardiometabolic pathways, and frailty: A two-step Mendelian randomization analysis

    Medicine

Length of stay

downin humans1OR 0.52

1 study
  1. Coronary artery disease is linked with lower length of stay in humans (acute pulmonary edema) (OR 0.52; 95% CI: 0.28-0.98; P = .042).

    “The history of coronary artery disease was independently associated with lower odds of prolonged hospitalization (OR 0.52; 95% CI: 0.28-0.98; P = .042).”

    Humansacute pulmonary edeman = 253

    Do frailty screening tools assessed at emergency department presentation predict in-hospital mortality and length of stay in older adults with acute pulmonary edema?: A prospective cohort study

    Medicine

Iron

upin humans1

1 study
  1. Coronary artery disease is linked with higher iron in humans (specifically in watershed regions).

    “the coronary artery disease group showed lower myelin and higher iron content, as measured by lower MTsat and R1, and higher susceptibility specifically in watershed regions”

    Humansspecifically in watershed regionsnormal-appearing white matter

    Coronary Artery Disease Is Linked with Demyelination and Iron Deposition in White Matter Watershed Areas

    Aging and disease

More on Iron

All 35

Upstream

40

Apolipoprotein B

mediatesin humans1no changein humans1HR 1.15

2 studies
  1. Apolipoprotein B is linked with coronary artery disease in leanness with metabolic dysfunction.

    “the unhealthy lean through apolipoprotein B, blood pressure and diabetes, sharing no other conduit”

    Humansin leanness with metabolic dysfunctionn = 60,801

    Divergent genetic mediator signatures of adiposity-related metabolic liabilities and coronary artery disease

    medRxivPreprint

  2. Apolipoprotein B was not clearly linked with coronary artery disease in humans among participants with CAC 0, compared with CAC 0 and normal ApoB (HR 1.15 (95% CI 0.59–2.23) for CAC 0 with high ApoB versus CAC 0 with normal ApoB).

    “Compared to group 1 (CAC 0 with normal ApoB), CAC 0 and high ApoB (group 2) was not associated with increased risk of CHD”

    Humansamong participants with CAC 0, compared with CAC 0 and normal ApoBmedian follow-up 13.9 years

    Coronary Artery Calcium Score Modifies the Risk of Coronary Heart Disease Associated with Apolipoprotein B

    AHA Scientific Sessions 2025 abstract

More on Apolipoprotein B

Triglyceride

mediatesin humans1no changein humans1

2 studies
  1. Triglyceride is linked with coronary artery disease in adiposity with metabolic dysfunction.

    “The unhealthy obese phenotype acted through triglycerides and diabetes”

    Humansin adiposity with metabolic dysfunctionn = 60,801

    Divergent genetic mediator signatures of adiposity-related metabolic liabilities and coronary artery disease

    medRxivPreprint

  2. Triglyceride was not clearly linked with coronary artery disease in humans (HDL-C ≥ 1.8 mmol/L).

    “For participants with HDL-C ≥ 1.8 mmol/L, no increase was observed in CAD risk associated with TG levels in either men or women.”

    HumansHDL-C ≥ 1.8 mmol/Lmean follow-up of 5.55 ± 2.39 years

    The Relationship Between Triglycerides and Coronary Artery Disease Stratified by Sex and High-Density Lipoprotein Cholesterol in Men and Women

    Diabetes/metabolism research and reviews

More on Triglyceride

Lipoprotein

no changein humans2HR 1.3

2 studies
  1. Lipoprotein was not clearly linked with coronary artery disease in humans (Lebanese adult tertiary-care cohort).

    “Logistic regression analysis showed no significant association between Lp(a) levels and cardiovascular factors including dyslipidemia, hypertension, coronary artery disease, previous coronary artery bypass graft, and previous myocardial infarction.”

    HumansLebanese adult tertiary-care cohortn = 456

    Distribution of Lipoprotein(a) Levels and Clinical Associations in a Lebanese Adult Population: A Retrospective Observational Study

    Journal of clinical medicine

  2. Lipoprotein was not clearly linked with coronary artery disease in humans (elevated Lp(a) without MetS compared to normal Lp(a) without MetS) (HR: 1.30; 95% CI: 0.94, 1.80).

    “those with elevated Lp(a) without MetS (group 2) did not have increased risk of CHD (HR: 1.30; 95% CI: 0.94, 1.80).”

    Humanselevated Lp(a) without MetS compared to normal Lp(a) without MetS

    Lipoprotein(a) and Metabolic Syndrome are Associated with Increased Risk of Coronary Heart Disease

    AHA Scientific Sessions 2025 abstract

More on Lipoprotein

Estimated glomerular filtration rate

mediatesin humans1

1 study
  1. Estimated glomerular filtration rate is linked with coronary artery disease in humans (Mediation of the association between APOL1 high-risk genotype and coronary artery disease) (27.7% mediated).

    “Baseline eGFR was the only consistent mediator, with a greater proportion mediated for coronary phenotypes, including CAD (27.7%) and myocardial infarction (26.5%)”

    HumansMediation of the association between APOL1 high-risk genotype and coronary artery diseasen = 3,303

    Kidney-risk gene variants linked to heart and blood vessel disease

    AHA Scientific Sessions 2026 abstract

More on Estimated glomerular filtration rate

Insomnia

mediatesin humans1

1 study
  1. Insomnia is linked with coronary artery disease in humans (partial mediation of the predisposing effect of veillonella unclassified) (5.7% mediated).

    “insomnia partially mediated the causal, predisposing effect of species Veillonella unclassified on increased CAD risk, with a proportion mediated of 5.7%.”

    Humanspartial mediation of the predisposing effect of veillonella unclassified

    Gut microbiota, sleep and coronary artery disease: A Mendelian randomization study

    Medicine

More on Insomnia

Frailty-related metabolic signature

mediatesin humans1

1 study
  1. Frailty-related metabolic signature is linked with coronary artery disease in humans (18.5%, 95% CI 15.7-21.7).

    “A 36-metabolite frailty-related signature showed an estimated mediation proportion of 18.5% (95% CI 15.7-21.7) in the frailty-CAD association.”

    Humans14.8 years

    Metabolic signature links frailty to coronary artery disease

    The journal of nutrition, health & aging

More on Frailty-related metabolic signature

Breast cancer

no changein humans1

1 study
  1. Breast cancer was not clearly linked with coronary artery disease in humans.

    “In contrast, BCa was not significantly associated with risk of coronary artery disease.”

    Humansfemales

    Genetic risk stratification of common diseases in breast cancer survivors: a population-based cohort study

    JNCI cancer spectrum

More on Breast cancer

Circulating ApoB

mediatesin humans1

1 study
  1. Circulating ApoB is linked with coronary artery disease in humans (instruments partitioned by effect on ApoB-containing lipoproteins).

    “the CAD effects are determined more by effects of circulating ApoB rather than liver fat itself”

    Humansinstruments partitioned by effect on ApoB-containing lipoproteins

    Liver fat accumulation contributes to discordant genetic risk between coronary artery disease and type 2 diabetes

    medRxivPreprint

More on Circulating ApoB

Menopausal timing

no changein humans1OR 0.97

1 study
  1. Menopausal timing was not clearly linked with coronary artery disease in humans (genetically determined) (OR 0.97, 95% CI 0.87-1.07).

    “genetically determined menopausal timing was not significantly associated with the risk of coronary heart disease (OR = 0.97; 95% CI, 0.87-1.07; P = 0.52”

    Humansgenetically determined

    Insights into the relationship between menopausal timing and risk of cardiovascular disease: a systematic review and meta-analysis of Mendelian randomization analyses

    Systematic reviews

Methylation risk score

mediatesin humans1

1 study
  1. Methylation risk score is linked with coronary artery disease in humans (association between stress and CHD) (16.5-17.7%).

    “mediated 16.5-17.7% of the association between stress and CHD”

    Humansassociation between stress and CHD

    Stress-Related Methylation Risk Scores Predict Coronary Heart Disease

    medRxiv : the preprint server for health sciencesPreprint

More on Methylation risk score

All 40

Associations

533

Lipoprotein

upin humans20upin reviews2downin humans1OR 1.012–1.31

23 studies
  1. Lipoprotein is associated with coronary artery disease in humans (Per genetically predicted 100 nmol/L increase) (OR 1.31, 95% CI 1.29–1.33).

    “genetically predicted lipoprotein(a) was strongly associated with increased risk of coronary artery disease (OR 1.31, 95% CI 1.29–1.33)”

    HumansPer genetically predicted 100 nmol/L increasen = 181,522

    Genetically predicted lipoprotein(a), first and recurrent venous thromboembolism, and coagulation proteins: evidence against causal relationships

    Journal of thrombosis and thrombolysis

  2. Lipoprotein predicts coronary artery disease in humans (aHR 1.42, 95% CI 1.15-1.74).

    “FDRs whose index participant had Lp(a) in the highest decile had higher CAD risk”

    HumansIndex participant lipoprotein(a) in the highest decile versus bottom half; incident disease in first-degree relatives13.9 years median follow-up

    Index Lipoprotein(a) and Polygenic Risk Score Identify Coronary Artery Disease Risk in First-Degree Relatives

    AHA Scientific Sessions 2026 abstract

  3. Lipoprotein is associated with coronary artery disease in humans (Approximate OR per doubling 1.07, 95% CrI 1.06–1.08).

    “Overall, Lp(a) was associated with increased risk of CAD (approximate OR per doubling of Lp(a) 1.07, 95% CrI 1.06 - 1.08).”

    HumansPer doubling of genetically inferred Lp(a)n = 657,692

    A blood particle’s heart disease link is similar across ancestries

    AHA Scientific Sessions 2026 abstract

  4. Lipoprotein is linked with a higher risk of coronary artery disease in humans (Inverse-variance weighted Mendelian randomization) (IVW OR 1.15, 95% CI 1.13–1.17).

    “Mendelian randomization confirmed causal effects on PAD (IVW OR=1.05, 95% CI 1.04-1.07) and CAD (IVW OR=1.15, 95% CI 1.13-1.17)”

    HumansInverse-variance weighted Mendelian randomization60% femalesn = 378,834

    Blood particle linked to differing artery disease risks

    AHA Scientific Sessions 2026 abstract

  5. Lipoprotein is associated with coronary artery disease in humans (Hypercholesterolemia; elevated lipoprotein(a) versus non-elevated lipoprotein(a)) (7.4% vs 6.1%; HR 1.20, 95% CI 1.10–1.32).

    “new coronary artery disease (7.4% vs 6.1%; RR 1.21, 95% CI 1.10-1.32; HR 1.20, 95% CI 1.10-1.32; P<0.001)”

    HumansHypercholesterolemia; elevated lipoprotein(a) versus non-elevated lipoprotein(a)1,095 daysn = 15,925

    Elevated Lipoprotein(a) and Cardiovascular Outcomes in Adults with Hypercholesterolemia: A Comparative Observational Study

    AHA Scientific Sessions 2026 abstract

  6. Lipoprotein is linked with a higher risk of coronary artery disease in humans (OR 1.21, 95% CI 1.12-1.32).

    “CAD (OR 1.21, 95% CI 1.12-1.32)”

    Humansn = 23,654

    Distribution of lipoprotein(a) and its association with atherosclerotic cardiovascular disease in a large real-world Polish cohort

    Journal of clinical lipidology

  7. Lipoprotein is associated with coronary artery disease in humans.

    “Higher Lp(a) grades were associated with the prevalence of coronary artery disease (CAD)”

    Humans

    Cross-Sectional Association of Lipoprotein(a) Levels With Vascular Complications and Related Parameters in a Japanese Type 2 Diabetes Cohort

    Journal of atherosclerosis and thrombosis

  8. Lipoprotein is associated with coronary artery disease in humans (history of coronary artery disease).

    “Elevated Lp(a) was associated with a history of coronary artery disease (p-trend=0.003) and with treatment with high-intensity statins alone (p-trend=0.032) or in combination with ezetimibe (p-trend=0.014).”

    Humanshistory of coronary artery diseasen = 388

    Lipoprotein(a) and acute coronary syndrome: Associations with sex, age and traditional cardiovascular risk factors

    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

  9. Lipoprotein is linked with a higher risk of coronary artery disease in humans (biomarker elevation) (HR 1.20 (95% CI: 1.12-1.29)).

    “1.20 (95% CI: 1.12-1.29) for Lp(a)”

    Humansbiomarker elevation12 yearsn = 215,695

    Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk: UK Biobank Study

    Journal of the American College of Cardiology

  10. Lipoprotein is linked with a lower risk of coronary artery disease in humans (Lp(a) < 50 mg/dL and IL-6 < median) (HR 0.65, 95% CI 0.56-0.74).

    “IL-6 levels below the median and Lp(a) concentrations below 50 mg/dL were also independently and additively associated with lower CHD risk”

    HumansLp(a) < 50 mg/dL and IL-6 < mediann = 408,687

    Genetic variants lowering lipoprotein(a) and downregulating interleukin-6 signalling are additively associated with a decreased risk of cardiovascular disease

    European journal of preventive cardiology

All 24

More on Lipoprotein

Polygenic risk score

upin humans14HR 1.37–7.1

14 studies
  1. Polygenic risk score is associated with coronary artery disease in humans (Q4 versus Q1 polygenic risk score; association attenuated with age) (Q4-vs-Q1 HR 7.1 at age 45 and 2.5 at age 70; -0.18/yr).

    “For CAD, the observed Q4-vs-Q1 PRS hazard ratio fell from 7.1 at age 45 to 2.5 at age 70 (-0.18/yr);”

    HumansQ4 versus Q1 polygenic risk score; association attenuated with age

    Modeling genetic risk by age improved disease prediction

    AHA Scientific Sessions 2026 abstract

  2. Polygenic risk score is associated with coronary artery disease in humans (High polygenic risk score in index patients) (OR 3.23; 95% CI 2.83–3.69).

    “High PRS in the index patients was significantly associated with all CM traits, including CAD (OR 3.23; 95%CI 2.83-3.69).”

    HumansHigh polygenic risk score in index patients41.2% malesn = 26,796

    Quantifying genetic, lifestyle and socioeconomic mediation of familial cardiometabolic risk

    ESC Congress 2026 abstract

  3. Polygenic risk score predicts coronary artery disease in individuals with chronic kidney disease, accounting for PREVENT risk factors.

    “A PRS of CHD was significantly associated with a 21% hazard of CHD in the PRS+PREVENT risk model (95% CI, [1.06-1.39], 2-sided Wald test P =5.5×10 -3 ).”

    Humansin individuals with chronic kidney disease, accounting for PREVENT risk factors10-year

    Polygenic Risk Scores of Coronary Heart Disease in Chronic Kidney Disease Population: The CRIC Study

    Circulation. Genomic and precision medicine

  4. Polygenic risk score is associated with coronary artery disease in humans (Adjusted subdistribution HR 1.37 per 1 SD; 95% CI 1.21–1.55).

    “Each 1-SD increase in the principal component-adjusted PRS was associated with the primary endpoint (adjusted subdistribution hazard ratio, 1.37; 95% CI, 1.21-1.55; p < 0.001).”

    HumansWithout baseline coronary artery disease; per 1-SD increase in principal component-adjusted polygenic risk scoreMedian follow-up of 6.8 yearsn = 2,067

    Development and internal-external validation of an interpretable machine learning model integrating clinical and polygenic predictors for coronary artery disease: a multicenter retrospective cohort study

    Frontiers in cardiovascular medicine

  5. Polygenic risk score predicts coronary artery disease in humans (combined with age and sex) (AUC 0.910).

    “the PRS models demonstrated strong predictive performance for coronary artery disease, atherosclerosis, and ischemic stroke, with area under the curve values of 0.910, 0.926, and 0.854, respectively.”

    Humanscombined with age and sex

    Evaluation of population-specific polygenic risk scores for blood lipids: insights from Taiwanese cohorts and multiancestry meta-analysis

    Frontiers in bioinformatics

  6. Polygenic risk score is linked with a higher risk of coronary artery disease in individuals with baseline CAC=0 (HR 3.12, 95% CI 1.05-9.31).

    “Individuals in the Top 5% PRS group had higher risk of CAD events compared with the remainder (hazard ratio [HR], 3.12; 95% CI, 1.05-9.31; P=0.041).”

    Humansin individuals with baseline CAC=0

    Prediction of incident coronary artery disease in individuals with zero coronary artery calcium using a novel multi-ancestry, label-free polygenic risk score framework

    medRxivPreprint

  7. Polygenic risk score is associated with coronary artery disease in humans (nonobstructive CAD on coronary angiography) (OR 1.26, 95% CI 1.14-1.39).

    “increasing levels of the polygenic risk score were strongly associated with increased prevalence of nonobstructive and obstructive CAD on coronary angiography (odds ratio, 1.26 [95% CI, 1.14-1.39]”

    Humansnonobstructive CAD on coronary angiography

    Angiographic Burden of Coronary Atherosclerosis Partially Mediates the Association Between ASCVD Risk Factors and Outcomes

    Circulation. Genomic and precision medicine

  8. Polygenic risk score predicts coronary artery disease in humans (White participants with high polygenic risk score).

    “Among White participants, both high PRS and elevated ePWV independently predicted CAD, with a potential mitigating interaction effect.”

    HumansWhite participants with high polygenic risk scoren = 4,741

    Integrating Vascular Aging and Genetic Risk: The Combined Impact of Estimated Pulse Wave Velocity and Genetic Predisposition on Coronary Artery Disease

    Journal of the American Heart Association

  9. Polygenic risk score is linked with a higher risk of coronary artery disease in humans (HR 1.88, 95% CI 1.84–1.91).

    “Each standard deviation (SD) increase in PRS was associated with a 1.88-fold increase in incident CAD risk (95% CI: 1.84, 1.91).”

    Humansn = 409,877

    Interactions Between Polygenic Risk Scores and Social Determinants of Health in Coronary Artery Disease: Insights from the UK Biobank

    AHA Scientific Sessions 2025 abstract

  10. Polygenic risk score is linked with a higher risk of coronary artery disease in humans (positive family history and high polygenic risk score) (OR: 3.26; 95% CI: 3.03 - 3.50).

    “essential hypertension (OR: 2.26; 95% CI: 2.16 - 2.37), and CAD (OR: 3.26; 95% CI: 3.03 - 3.50).”

    Humanspositive family history and high polygenic risk scoren = 103,566

    Impact of Family History and Polygenic Risk Scores on Cardiometabolic Disease Risk

    AHA Scientific Sessions 2025 abstract

All 14

More on Polygenic risk score

Mortality

upin humans9HR 1.56–2

9 studies
  1. Coronary artery disease predicts mortality in humans (Older Thai adults with positive screening FOBT) (aHR 1.88, 95% CI 1.11–3.20).

    “Independent mortality predictors included end-stage renal disease (aHR 2.14, 95% CI 1.22–3.76), coronary artery disease (aHR 1.88, 95% CI 1.11–3.20)”

    HumansOlder Thai adults with positive screening FOBT5 yearsn = 709

    Illness burden linked to survival in older Thai adults

    Research SquarePreprint

  2. Coronary artery disease is associated with mortality in humans (Adults with congenital heart disease; multivariable analysis) (HR 1.78).

    “coronary artery disease (HR 1.78; P = .005)”

    HumansAdults with congenital heart disease; multivariable analysisMedian follow-up of 10.0 years50.3% malesn = 9,826

    Adults with congenital heart disease: the growing impact of acquired cardiovascular risk factors on late mortality

    European heart journal

  3. Coronary artery disease is associated with mortality in humans (combined with hypertension) (Overall AAMR rose from 57.22 to 76.95).

    “Overall AAMR rose from 57.22 to 76.95, driven by a steep 2018-2021 increase (APC: 10.13%) before a recent decline (2021-2024, APC: -3.50%).”

    Humanscombined with hypertension2000 to 2024n = 3,776,396

    Temporal Trends and Demographic Disparities in Mortality Due to Coronary Artery Disease and Hypertension in Adults Aged 25 and Above in the United States (2000 to 2024)

    Clinical cardiology

  4. Coronary artery disease is linked with a higher risk of mortality in humans (multivariable Cox regression in patients under best medical therapy) (HR 2.0, 95% CI 1.3-3.0).

    “coronary artery disease (HR, 2.0; 95% CI, 1.3-3.0; P < .001)”

    Humansmultivariable Cox regression in patients under best medical therapy

    A score system to determine the 5-year survival in patients with asymptomatic carotid stenosis under best medical therapy: Results from the Carotid Asymptomatic Stenosis study

    Journal of vascular surgery

  5. Mortality is associated with coronary artery disease in humans (concurrent aortic stenosis and coronary artery disease in males vs females) (26.32 vs. 12.15 in 2024).

    “Males had higher AAMRs than females (26.32 vs. 12.15 in 2024).”

    Humansconcurrent aortic stenosis and coronary artery disease in males vs females2024males

    Trends and Disparities in Aortic Stenosis and Coronary Artery Disease-Related Mortality Among U.S. Adults Aged ≥65 Years, 1999-2024

    Annals of vascular surgery

  6. Coronary artery disease is linked with a higher risk of mortality in humans.

    “In multivariable Cox models, age and coronary artery disease were consistently associated with higher all-cause mortality across all model specifications.”

    Humansn = 480

    Prognostic value of serum albumin and inflammatory markers for long-term all-cause mortality across the cardio-kidney-metabolic spectrum: a real-world cohort study

    BMC cardiovascular disorders

  7. Coronary artery disease predicts mortality in humans (PAD patients undergoing endovascular revascularization) (HR 1.56).

    “coronary artery disease (CAD) (HR 1.56, p < 0.001)”

    HumansPAD patients undergoing endovascular revascularizationn = 476

    Predictors of Mortality in Peripheral Arterial Disease After Endovascular Lower Limb Revascularization and Development of a Risk Score Based Solely on Clinical Presentation

    Journal of clinical medicine

  8. Coronary artery disease is linked with a higher risk of mortality in humans (COVID-19) (OR=7.68, 95%CI=3.52-17.07, P<0.001).

    “coronary heart disease(OR=7.68, 95%CI=3.52-17.07, P<0.001)”

    HumansCOVID-19

    Analysis of Influencing Factors of Death in the Elderly With Coronavirus Disease 2019 Based on Propensity Score Matching

    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

  9. Coronary artery disease is linked with a higher risk of mortality in humans (acute stroke treated with reperfusion therapies) (OR = 8.02, 95% CI: 1.66-38.68).

    “In nonagenarians, previous coronary artery disease (OR = 8.02, 95% CI: 1.66-38.68, p = 0.01)”

    Humansacute stroke treated with reperfusion therapies3 months

    Acute Reperfusion Therapies and Prognosis in Nonagenarian Stroke Patients

    Gerontology

Clonal hematopoiesis of indeterminate potential

upin humans5upin reviews1HR 1.41

6 studies
  1. Clonal hematopoiesis of indeterminate potential is associated with coronary artery disease in humans (patients undergoing treatment for solid tumors).

    “Patients with CHIP were more likely to have coronary artery disease (CAD) (p-value <0.001) and HFpEF (p-value 0.007)”

    Humanspatients undergoing treatment for solid tumorsn = 236

    Clonal hematopoiesis of indeterminate potential (CHIP) is associated with increased risk of diastolic dysfunction in a cardio-oncology cohort

    ESC Congress 2026 abstract

  2. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of coronary artery disease in humans (HR = 1.41; 95% CI: 1.17-1.72).

    “A favorable lifestyle and CHIP were associated with 53% lower (HR (hazard ratio) = 0.47; 95% CI (confidence interval): 0.36-0.61) and 41% higher (HR = 1.41; 95% CI: 1.17-1.72) CAD risk, respectively.”

    Humans12.1 yearsn = 6,113

    Healthy habits may curb heart risk linked to blood mutations

    Fundamental research

  3. Clonal hematopoiesis of indeterminate potential raises the risk of coronary artery disease in humans.

    “Clinical cohort data link CHIP to increased risk of coronary heart disease, early-onset myocardial infarction, and mortality following transcatheter aortic valve implantation.”

    Review

    THE HEMATOLOGIC TROJAN HORSE: CLONAL HEMATOPOIESIS AND THE NEXT FRONTIER OF CARDIOVASCULAR MEDICINE

    Northwest journal of medical sciences.

  4. Clonal hematopoiesis of indeterminate potential raises the risk of coronary artery disease.

    “Epidemiological studies consistently demonstrate that CH is independently associated with increased risks of coronary artery disease, heart failure, aortic stenosis, and cardiovascular mortality.”

    Review

    Clonal hematopoiesis and atherosclerotic cardiovascular disease: Clinical implications, biological mechanisms, and emerging therapeutic strategies

    Journal of the Formosan Medical Association = Taiwan yi zhi

  5. Clonal hematopoiesis of indeterminate potential raises the risk of coronary artery disease in large human cohorts.

    “CHIP is associated with increased risk of coronary artery disease and other atherosclerosis-related outcomes”

    Reviewin large human cohorts

    Hematopoietic somatic mutations in atherosclerotic cardiovascular disease

    Atherosclerosis

  6. Clonal hematopoiesis of indeterminate potential is associated with coronary artery disease in humans.

    “Age-related clonal haematopoiesis arises from ageing-related DNA damage and is associated with haematological neoplasms and coronary artery disease.”

    Review

    Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time

    The Lancet. Haematology

More on Clonal hematopoiesis of indeterminate potential

Frailty

upin humans6HR 1.78–2.98

6 studies
  1. Frailty is linked with a higher risk of coronary artery disease in humans (HR 1.78, 95% CI 1.59-1.99).

    “Frailty was associated with higher CAD risk (hazard ratio [HR] 1.78; 95% confidence interval [CI] 1.59-1.99).”

    Humans14.8 yearsn = 223,907

    Metabolic signature links frailty to coronary artery disease

    The journal of nutrition, health & aging

  2. Coronary artery disease is associated with frailty in humans (regression analysis in patients on hemodialysis).

    “Regression analysis demonstrated that heart failure, cancer, and coronary artery disease/ischemic heart disease were significantly associated with frailty.”

    Humansregression analysis in patients on hemodialysis

    Prospective Evaluation of the FRAIL Scale as a Predictor of Hospitalization and All-Cause Mortality Among Patients with End-Stage Renal Disease on Hemodialysis

    Philippine Journal of Internal Medicine

  3. Frailty is associated with coronary artery disease in humans (p=0.01).

    “Participants categorised as prefrail or frail had higher body mass index (p=0.031) and more frequently presented with coronary artery disease (p=0.01) and multimorbidity (p=0.027) compared with robust individuals.”

    Humansn = 165

    Frailty and multimorbidity among adults aged 40-69 years in Montenegro: a cross-sectional pilot study

    BMJ open

  4. Frailty is linked with a higher risk of coronary artery disease in humans (HR = 2.98, 95 % CI: 2.45-3.62).

    “similar associations of frailty with CHD (HR = 2.98, 95 % CI: 2.45-3.62) and stroke (HR = 1.82, 95 % CI: 1.58-2.11) were observed”

    Humansmedian of 10.96 yearsn = 52,252

    Association between frailty status and the risk of cardiovascular diseases in Chinese adults: A prospective cohort study

    Public health

  5. Coronary artery disease is linked with a higher risk of frailty in humans.

    “Independent risk factors for frailty included age, coronary artery disease (CAD), old cerebral infarction (OCI), neutrophil, neutrophil to lymphocyte rate (NLR), high-sensitivity C-reactive protein (hs-CRP), albumin, fibrinogen to albumin ratio (FAR) and erythrocyte sedimentation rate (ESR).”

    Humansn = 800

    Inflammatory markers and clinical factors as key independent risk factors for frailty: a retrospective study

    BMC geriatrics

  6. Coronary artery disease is associated with frailty in humans (coronary heart disease) (36% (95%CI: 31%-40%)).

    “The pooled prevalence in older adults with coronary heart disease was 36% (95%CI: 31%-40%) for frailty.”

    Reviewcoronary heart diseasen = 11,954

    Prevalence and risk factors of frailty in older patients with coronary heart disease: A systematic review and meta-analysis

    Archives of gerontology and geriatrics

Hypertension

upin humans6OR 1.85–3.16

6 studies
  1. Hypertension is linked with a higher risk of coronary artery disease in humans (OR: 2.58, 95% CI: 1.75-3.80).

    “Hypertension (OR: 2.58, 95% CI: 1.75-3.80, p < 0.001)”

    Humansfemales

    Prevalence of Coronary Artery Diseases Among Adult Women Residents of Tehran: A Cross-Sectional Report From Tehran Cohort Study (TeCS)

    Cardiology research and practice

  2. Hypertension is associated with coronary artery disease in humans (urban residents) (aPOR 4.83, 95% CI 4.27–5.47).

    “hypertension (aPOR: 4.83; 95% CI: 4.27–5.47)”

    Humansurban residents

    Factors Associated with the Occurrence of Coronary Heart Disease (PJK) among Residents in Urban and Rural Areas: Analysis of Data from the 2023 Indonesian Health Survey (SKI)

    SEHATMAS Jurnal Ilmiah Kesehatan Masyarakat

  3. Hypertension is associated with coronary artery disease in homozygous familial hypercholesterolemia after propensity score matching (OR 1.85; 95%CI 1.11-3.08, p = 0.02).

    “hypertension was significantly associated with CAD (OR 1.85; 95%CI 1.11-3.08, p = 0.02)”

    Humansin homozygous familial hypercholesterolemia after propensity score matching

    Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry

    Atherosclerosis

  4. Hypertension is linked with a higher risk of coronary artery disease in humans (type 2 diabetes) (OR = 3.16, 95% CI: 2.23-4.46, p < 0.001).

    “hypertension (OR = 3.16, 95% CI: 2.23-4.46, p < 0.001)”

    Humanstype 2 diabetes

    Prevalence of macro-vascular complications among type 2 diabetic adults aged 50 and over: results from Ardakan cohort study on aging (ACSA)

    Journal of diabetes and metabolic disorders

  5. Hypertension is linked with a higher risk of coronary artery disease in humans (men of Japanese ancestry, adjusted for age and cardiovascular risk factors) (HR 1.61; 95% CI 1.44-1.80).

    “in men of Japanese ancestry, hypertension was a strong predictor of CAD (hazard ratio [HR] 1.61; 95% confidence interval [CI] 1.44-1.80)”

    Humansmen of Japanese ancestry, adjusted for age and cardiovascular risk factorsmalesn = 5,415

    FOXO3 Longevity Genotype Mitigates Risk Posed by Hypertension on Incident Coronary Artery Disease in Middle-Aged Men: Kuakini Honolulu Heart Program

    The journals of gerontology. Series A, Biological sciences and medical sciences

  6. Hypertension is associated with coronary artery disease in humans.

    “Higher prevalence rates were observed among older individuals, urban residents, those with higher education levels, males, and participants with hypertension, diabetes, and elevated total cholesterol levels.”

    Humans

    Prevalence of Coronary Artery Disease among Adults in Nepal

    Journal of Nepal Health Research Council

More on Hypertension

Triglyceride-glucose index

upin humans5HR 1.44–1.74

5 studies
  1. Triglyceride-glucose index is linked with a higher risk of coronary artery disease in humans (Q4 versus Q1) (HR 1.57 (95% CI 1.51-1.63)).

    “for incident CAD were 1.57 (1.51-1.63) for TyG”

    HumansQ4 versus Q1

    Insulin Resistance Indices and Genetic Predisposition in Relation to the Risk of Incident and Recurrent Coronary Artery Disease

    Journal of the American Heart Association

  2. Triglyceride-glucose index is associated with coronary artery disease in humans (adjusted HR 1.44, 95% CI 1.25–1.66).

    “coronary heart disease (aHR, 1.44; 95% CI, 1.25-1.66)”

    HumansHigher TyG index with comorbidity versus TyG index < 8.59 and no comorbidity; no baseline CVD9-year follow-upn = 9,400

    Triglyceride glucose index, metabolic comorbidity, and cardiovascular disease: a national cohort study

    BMC cardiovascular disorders

  3. Triglyceride-glucose index is associated with coronary artery disease in humans (postmenopausal women) (HR 1.74, 95% CI 1.52–1.99 per 1-unit increase).

    “CHD: HR = 1.74, 95 % CI: 1.52, 1.99;”

    Humanspostmenopausal women1-unit increaseup to 32 yearsfemalesn = 11,769

    Triglyceride-glucose index and cardiovascular disease by cardiovascular-kidney-metabolic syndrome and socioeconomic status among postmenopausal women

    Atherosclerosis

  4. Triglyceride-glucose index predicts coronary artery disease in humans (non-frail individuals) (OR = 1.89, 95% CI: 1.42-2.51).

    “In non-frail individuals, TyG independently predicted CHD (OR = 1.89, 95% CI: 1.42-2.51) with a near-linear relationship.”

    Humansnon-frail individuals

    Frailty Modifies the Predictive Capacity of the Triglyceride-Glucose Index for Coronary Heart Disease

    International heart journal

  5. Coronary artery disease is associated with triglyceride-glucose index in CHD vs non-CHD (p < 0.001).

    “Participants with CHD exhibited significantly higher TyG index values and inflammatory marker levels compared to non-CHD groups (p < 0.001).”

    Humansin CHD vs non-CHD

    Comparative study of triglyceride glucose index and coronary heart disease risk in middle aged and elderly Chinese and British populations

    Scientific reports

  6. Triglyceride-glucose index is linked with a higher risk of coronary artery disease in humans (highest TyG quartile (Q4) vs lowest quartile) (OR = 2.11, 95% CI: 1.51-2.89).

    “the highest TyG quartile (Q4) in China showed a 2.11-fold increased CHD risk (95% CI: 1.51-2.89)”

    Humanshighest TyG quartile (Q4) vs lowest quartile

    Comparative study of triglyceride glucose index and coronary heart disease risk in middle aged and elderly Chinese and British populations

    Scientific reports

More on Triglyceride-glucose index

Physical activity

downin humans3upin humans2HR 0.8–0.92

5 studies
  1. Physical activity is associated with coronary artery disease in humans (20% lower CHD risk; HR 0.8).

    “A 20% lower CHD risk (hazard ratio [HR], 0.8) was observed at approximately 60 minutes per week of moderate‐to‐vigorous physical activity in older adults”

    HumansModerate-to-vigorous physical activityApproximately 60 minutes per weekMedian follow-up of 7.88 yearsn = 31,663

    Activity’s link to heart disease risk differed by age

    Journal of the American Heart Association

  2. Physical activity is associated with coronary artery disease in humans (UK Biobank) (Active: HR 0.92, 95% CI 0.88–0.96; highly active: HR 0.89, 95% CI 0.86–0.92).

    “CHD events (active: HR 0.92; 95% CI, 0.88–0.96; highly active: HR 0.89; 95% CI, 0.86–0.92; P for trend < 0.001)”

    HumansUK Biobankhighly activen = 230,972

    Physical Activity, Blood Lipids, and Incident Cardiovascular Diseases: A Prospective Study Based on UK Biobank and China Kadoorie Biobank Participants

    Medicine and science in sports and exercise

  3. Physical activity is associated with coronary artery disease in humans (urban residents) (aPOR 1.48, 95% CI 1.25–1.76).

    “low physical activity (aPOR: 1.48; 95% CI: 1.25–1.76)”

    Humansurban residentslow

    Factors Associated with the Occurrence of Coronary Heart Disease (PJK) among Residents in Urban and Rural Areas: Analysis of Data from the 2023 Indonesian Health Survey (SKI)

    SEHATMAS Jurnal Ilmiah Kesehatan Masyarakat

  4. Physical activity predicts coronary artery disease in humans.

    “Finally, we found that PA variables demonstrated greater predictive utility than either FC or GMV alone, particularly for CHD and diabetes”

    Humans

    Exploring Links between Brain Image-Derived Phenotypes and Accelerometer-Measured Physical Activity in the UK Biobank

    bioRxivPreprint

  5. Physical activity is linked with a lower risk of coronary artery disease in humans after correcting for regression dilution (20% lower risk of CHD per usual 4000 steps).

    “the inverse association between daily step count and CHD showed a 20% lower risk of CHD per usual 4000 steps after correcting for regression dilution compared with 13% before correction”

    Humansafter correcting for regression dilutionper usual 4000 stepsn = 87,038

    Reproducibility and associated regression dilution bias of accelerometer-derived physical activity and sleep in UK Biobank

    International journal of epidemiology

More on Physical activity

Diabetes mellitus

upin humans5OR 2.07

5 studies
  1. Diabetes mellitus is linked with a higher risk of coronary artery disease in humans (OR: 2.07, 95% CI: 1.49-2.88).

    “diabetes mellitus (OR: 2.07, 95% CI: 1.49-2.88, p < 0.001)”

    Humansfemales

    Prevalence of Coronary Artery Diseases Among Adult Women Residents of Tehran: A Cross-Sectional Report From Tehran Cohort Study (TeCS)

    Cardiology research and practice

  2. Diabetes mellitus is associated with coronary artery disease in humans (urban residents) (aPOR 2.67, 95% CI 2.26–3.17).

    “diabetes mellitus (aPOR: 2.67; 95% CI: 2.26–3.17)”

    Humansurban residents

    Factors Associated with the Occurrence of Coronary Heart Disease (PJK) among Residents in Urban and Rural Areas: Analysis of Data from the 2023 Indonesian Health Survey (SKI)

    SEHATMAS Jurnal Ilmiah Kesehatan Masyarakat

  3. Diabetes mellitus is associated with coronary artery disease in peripheral arterial disease patients (77.4%, p= 0.008).

    “Diabetes mellitus was also significantly correlated as 77.4% patients with coronary artery disease were asymptomatic (p= 0.008).”

    Humansin peripheral arterial disease patients

    Association of Asymptomatic Coronary Heart Disease in Patients Presented with Peripheral Arterial Disease Undergoing Angiography

    Medical Forum Monthly

  4. Diabetes mellitus is associated with coronary artery disease in humans (age- and sex-adjusted) (PR 1.98 (95%CI: 1.66-2.37)).

    “In the multivariate model, the prevalence ratio for CHD history was 1.98 (95%CI: 1.66-2.37)”

    Humansage- and sex-adjusted

    Excess prevalence of chronic diseases in elderly people with diabetes and non-diabetics in Poland

    PloS one

  5. Diabetes mellitus raises the risk of coronary artery disease in patients with type 2 diabetes mellitus.

    “Diabetes mellitus increases the risk of developing coronary artery disease, stroke, aortic disease, heart failure, atrial fibrillation, and peripheral arterial disease.”

    Reviewin patients with type 2 diabetes mellitus

    Cardiac Rehabilitation and Cardiovascular Prevention in Patients with Type 2 Diabetes Mellitus: From Initial Assessment to Comprehensive Management

    Journal of clinical medicine

More on Diabetes mellitus

Low-density lipoprotein cholesterol

upin humans4downin humans1HR 0.56–1.6

5 studies
  1. Low-density lipoprotein cholesterol is associated with coronary artery disease in humans (low LDL-C levels (< 80 mg/dL)) (HR = 0.56).

    “and inversely associated with the coronary artery disease incidence (HR = 0.56) (all, P < 0.001).”

    Humanslow LDL-C levels (< 80 mg/dL)< 80 mg/dL6.3 yearsn = 283,289

    Low levels of low-density lipoprotein cholesterol in older adults are inversely associated with the incidence of coronary artery disease and all-cause mortality: the Shizuoka Kokuho Database study

    European geriatric medicine

  2. Low-density lipoprotein cholesterol is linked with a higher risk of coronary artery disease in humans (adjusted for covariates and 8-year values) (aHR 1.56 (95% CI: 1.02, 2.37)).

    “1.56 per 309 mg/dL-years of LDL-C (95% CI: 1.02, 2.37)”

    Humansadjusted for covariates and 8-year valuesper 309 mg/dL-years8-year cumulative exposure

    Cumulative exposure to risk factors and subsequent cardiovascular disease events: The Jackson Heart Study

    medRxiv : the preprint server for health sciencesPreprint

  3. Low-density lipoprotein cholesterol is linked with a higher risk of coronary artery disease in humans (HR 1.24, 95% CI 1.21-1.26).

    “CAD was more strongly associated with LDL-C (HR 1.24, 95% CI 1.21-1.26) and CAD polygenic risk score (PRS).”

    Humans13 yearsn = 468,266

    Risk factors for atherosclerosis diverge across vascular beds

    American journal of preventive cardiology

  4. Low-density lipoprotein cholesterol is linked with a higher risk of coronary artery disease in humans (biomarker elevation) (HR 1.60 (95% CI: 1.48-1.66)).

    “1.60 (95% CI: 1.48-1.66) for LDL-C”

    Humansbiomarker elevation12 yearsn = 215,695

    Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk: UK Biobank Study

    Journal of the American College of Cardiology

  5. Low-density lipoprotein cholesterol is linked with a higher risk of coronary artery disease in humans (UK Biobank participants) (HR 1.23, 95% CI 1.21–1.25).

    “CAD was more strongly linked to low-density lipoprotein cholesterol (LDL-C; HR 1.23, 95% CI 1.21–1.25), the CAD polygenic risk score (PRS), and systolic blood pressure (SBP).”

    HumansUK Biobank participantsn = 468,266

    Multidomain Risk Profiles and Disease Progression Across Atherosclerotic Vascular Beds

    AHA Scientific Sessions 2025 abstract

More on Low-density lipoprotein cholesterol

Omega-3 fatty acids

downin humans2downin reviews1HR 0.88–0.93

3 studies
  1. Omega-3 fatty acids lower the risk of coronary artery disease in humans (absolute risk difference of −0.47% (95% CI: −0.84, −0.10)).

    “On average, omega-3 FA supplementation reduced the 5-year CHD risk, with an absolute risk difference of −0.47% (95% CI: −0.84, −0.10).”

    Human trialalmost 5 yearsn = 25,871

    Identification of individuals who benefit from omega-3 fatty acid supplementation to prevent coronary heart disease: a machine-learning analysis of the VITAL

    European journal of epidemiology

  2. Omega-3 fatty acids lower the risk of coronary artery disease in humans (top tertile of the expected benefit) (1.21% absolute risk reduction vs 0.47% average).

    “there was 1.21% absolute CHD risk reduction in the top tertile of the expected benefit, compared with the average effect of 0.47% risk reduction.”

    Human trialtop tertile of the expected benefit5-yearn = 25,871

    Identification of individuals who benefit from omega-3 fatty acid supplementation to prevent coronary heart disease: a machine-learning analysis of the VITAL

    European journal of epidemiology

  3. Omega-3 fatty acids lower the risk of coronary artery disease in humans.

    “According to primary informed priors, probabilities of omega-3 FA being effective versus placebo (i.e. posterior HR < 1) were 99.7% for CHD, 99.6% for total MI, 98.4% for CVD, 98.8% for all-cause death, 99.8% for cardiovascular death, and 33.7% for stroke, respectively.”

    Human trial1 g per daymedian of 5.3 years (range, 3.8 to 6.1)n = 25,871

    A Bayesian analysis of the VITAL trial: effects of ω-3 fatty acid supplementation on cardiovascular events

    The American journal of clinical nutrition

  4. Omega-3 fatty acids lower the risk of coronary artery disease in humans (posterior HR 0.88 to 0.93).

    “The effects of ω-3 FA supplementation on CAD and MI were robust across the priors, with the posterior HR estimates varying from 0.88 to 0.93”

    Human trial1.2:1840 mg/d5.3 yn = 25,871

    A Bayesian analysis of the VITAL trial: effects of ω-3 fatty acid supplementation on cardiovascular events

    The American journal of clinical nutrition

  5. Omega-3 fatty acids lower the risk of coronary artery disease (dose-dependent reduction).

    “Omega-3 supplementation reduces coronary heart disease and myocardial infarction risk dose-dependently”

    Reviewdose-dependent reduction

    Diet and Risk of Cardiovascular Disease

    The American journal of medicine

More on Omega-3 fatty acids

Conjugated equine estrogens + medroxyprogesterone acetate

upin humans2HR 2.77

2 studies
  1. Conjugated equine estrogens + medroxyprogesterone acetate raises the risk of coronary artery disease in humans (elevated LDL 190 mg/dL or higher in untreated postmenopausal women) (HR 2.77; 95% CI, 1.42-5.40).

    “for elevated LDL 190 mg/dL or higher, the risks were more than doubled (HR 2.77; 95% CI, 1.42-5.40; P -trend=.002).”

    Human trialelevated LDL 190 mg/dL or higher in untreated postmenopausal womenoral0.625 mg/d CEE + 2.5 mg/d MPAfemales

    Influence of Cardiometabolic Status on Cardiovascular Effects of Oral Menopausal Hormone Therapy

    Obstetrics and gynecology

  2. Conjugated equine estrogens + medroxyprogesterone acetate is associated with coronary artery disease in humans (postmenopausal women).

    “conjugated equine estrogen (CEE) with medroxyprogesterone acetate (MPA), is associated with increased coronary heart disease and stroke risk”

    Reviewpostmenopausal womenoral syntheticfemales

    Cardiovascular Risk Associated with Menopause and Menopause Hormone Therapy: A Review and Contemporary Approach to Risk Assessment

    Current atherosclerosis reports

More on Conjugated equine estrogens + medroxyprogesterone acetate

Conjugated equine estrogens with medroxyprogesterone acetate

upin humans1HR 1.47

1 study
  1. Conjugated equine estrogens with medroxyprogesterone acetate raises the risk of coronary artery disease in humans among women without baseline statin use, women with an intact uterus (HR 1.47 (95% CI 1.13-1.90)).

    “For CEE+MPA, there was also no difference by statin use, HR = 1.02 (95% CI: 0.55-1.89) and HR = 1.47 (95% CI: 1.13-1.90), respectively.”

    Human trialamong women without baseline statin use, women with an intact uterus5 yearsfemales

    Baseline use of aspirin or statins with oral estrogen and progestogens to prevent incident arterial or venous thrombotic events: a secondary analysis of the Women's Health Initiative trial

    Menopause (New York, N.Y.)

More on Conjugated equine estrogens with medroxyprogesterone acetate

All 533

Trial sponsors

Funding

44 grants since 2016

National Heart, Lung, and Blood Institute$26.4MGouvernement du Canada | Canadian Institutes of Health ResearchCA$613KFogarty International Center$298K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies associate frailty and cardiovascular biological age gap with coronary artery disease. Lipid and polygenic risk measures track disease risk, although a cohort finds no polygenic-score association in Black participants but an association in White participants with high scores; statin use associates with lower risk in high-polygenic-risk groups.

  2. Summary rewritten as its findings changed.

    As it read before

    Human cohorts link higher LDL cholesterol, metabolic syndrome and frailty to coronary artery disease risk. Dietary associations differ: a healthy plant-based score relates to lower risk, whereas an overall plant-based score relates to higher incidence but lower mortality. A human trial finds no effect of screening on coronary disease in asymptomatic adults with diabetes and no known disease.

  3. Summary rewritten as its findings changed.

    As it read before

    In human cohorts, coronary artery disease risk increases with elevated low-density lipoprotein cholesterol, higher triglyceride-glucose index, frailty, and prolonged mobile phone call duration. In human observational data, the disease impairs specific cognitive tasks without altering global cognition.

  4. Summary written from the findings.

Latest

medRxiv

Genetic study finds no lower artery disease risk for immune target

Heart artery disease odds were slightly higher, with an odds ratio of 1.06 per genetically predicted 19% decrease in a blood inflammation marker.Heart artery disease odds were slightly higher, with an odds ratio of 1.06 per genetically predicted 19% decrease in a blood inflammation marker.

Preprint: Mendelian randomizationBlood and immune system
The American Journal of Clinical Nutrition

Carbohydrate quality linked to multiple heart and metabolic diseases

For developing at least three heart and metabolic diseases, hazard ratios were 0.92 for high-quality carbohydrates and 1.11 for low-quality carbohydrates.For developing at least three heart and metabolic diseases, hazard ratios were 0.92 for high-quality carbohydrates and 1.11 for low-quality carbohydrates.

Cohort · 177,763 peoplePopulations
Global Heart

Ideal heart health linked to lower cardiovascular disease risk

Ideal versus poor heart health was associated with a 53% lower relative risk of cardiovascular disease in 242,951 UK Biobank participants.Ideal versus poor heart health was associated with a 53% lower relative risk of cardiovascular disease in 242,951 UK Biobank participants.

Cohort · 242,951 peopleCardiovascular disease

See all 3,999 papers on coronary artery disease